Facebook
Twitter
Telegram
Report an ErrorTFF Pharmaceuticals Financial Statements 2011-2024 | TFFP
Annual Financial Statements TFF Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
10.8 M | 815 K | 220 M | 318 M | 36 M | - | - | - | - | - | - | - | - |
Shares |
1.79 M | 1.2 M | 24.8 M | 20.4 M | 6.9 M | - | - | - | - | - | - | - | - |
Historical Prices |
6.05 | 0.68 | 8.87 | 14.3 | 5.35 | - | - | - | - | - | - | - | - |
Net Income |
-21.2 M | -31.8 M | -31 M | -18.6 M | -11.9 M | - | -179 K | - | - | - | - | - | - |
Revenue |
734 K | 496 K | 88.2 K | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-21.9 M | -31.8 M | -31.8 M | -18.7 M | -12 M | -3.9 M | - | - | - | - | - | - | - |
Interest Expense |
14.5 K | 26.7 K | 51.2 K | 126 K | 117 K | 56 K | - | - | - | - | - | - | - |
EBITDA |
-21.4 M | -31.4 M | -31.7 M | -18.7 M | -12 M | - | -179 K | - | - | - | - | - | - |
Operating Expenses |
22.6 M | 32.3 M | 31.9 M | 18.7 M | 12 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
10.6 M | 13.8 M | 293 K | 8.01 M | 3.17 M | - | 179 K | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement TFF Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
47.4 M | 36.2 M | 36.2 M | 36.2 M | 25.5 M | 25.4 M | 25.4 M | 25.4 M | 25.4 M | 25.4 M | 23.1 M | 22.5 M | 400 K | 19.1 M | 400 K | 18.5 M | 400 K | 400 K | 400 K | 4 M | 4.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-4.41 M | -5.02 M | -7.05 M | - | -7.27 M | -8.75 M | -8.38 M | - | -8.68 M | -4.66 M | -7.65 M | - | -5.06 M | -3.82 M | -3.8 M | - | -2.84 M | -2.19 M | -2.18 M | - | -585 K | -2.12 M | -268 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
235 K | 333 K | 51.4 K | - | 87.6 K | 28 K | 67.4 K | - | 50 K | 1.85 K | 24.3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-4.42 M | -5.02 M | -7.09 M | - | -7.28 M | -8.75 M | -8.38 M | - | -8.68 M | -5.11 M | -7.9 M | - | -5.08 M | -3.84 M | -3.85 M | - | -2.86 M | -2.21 M | -2.2 M | - | -606 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | 36.1 K | 35.1 K | - | 6.12 K | 5.88 K | 7.18 K | - | 12.1 K | 14.1 K | 15.5 K | - | 20.5 K | 26 K | 56.3 K | - | 25.9 K | 22.2 K | 19.6 K | - | 20.9 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -6.96 M | - | -7.01 M | -8.59 M | -8.31 M | - | -8.64 M | -5.11 M | -7.9 M | - | -5.08 M | -3.84 M | -3.85 M | - | -2.86 M | -2.21 M | -2.2 M | - | -606 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
4.66 M | 5.35 M | 7.14 M | - | 7.37 M | 8.78 M | 8.45 M | - | 8.73 M | 5.11 M | 7.93 M | - | 5.08 M | 3.84 M | 3.85 M | - | 2.86 M | 2.21 M | 2.2 M | - | 606 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.27 M | 2.67 M | 3.12 M | - | 3.34 M | 3.68 M | 3.21 M | - | 2.39 M | 2.35 M | 2.65 M | - | 2.25 M | 1.27 M | 1.62 M | - | 301 K | 889 K | 532 K | - | 466 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency